WHO_HTM_TB_2009_420_10

If a daily continuation phase is not possible for these patients, three times
weekly dosing during the continuation phase is an acceptable alternative.

Grade Certainty of evidence
moderate
Grade Strength
conditional
Grade Certainty of evidence label
in_the_evidence
Recommendation Direction
neutral